A synthetic delivery vector for mucosal vaccination
Description
The success of mRNA-based vaccines during the Covid-19 pandemic has highlighted the value of this new platform for vaccine development against infectious disease. However, the CD8^(+) T cell response remains modest with mRNA vaccines, and these do
